Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AB Science

AB Science
2001 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
AB STOCK SYMBOL
$8.70 SHARE PRICE (As of Wednesday Closing)
Description

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 3, Avenue George V
  • 75008 Paris
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AB Science’s full profile, request a free trial.

AB Science Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.60 - $11.87 $388M $7.65 -$0.84 301K 44.6M

AB Science Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 211,839 149,158 367,923 534,554
Revenue 1,848 2,007 1,961 1,668
EBITDA (24,299) (29,660) (30,198) (29,037)
Net Income (31,889) (30,754) (30,587) (30,636)
Total Assets 20,707 25,728 60,705 39,975
Total Debt 13,368 10,699 11,200 9,822
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AB Science Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AB Science‘s full profile, request access.

Request full access to PitchBook

AB Science Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedDay Pharmaceuticals Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
00000 Formerly PE-Backed Paris, France 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed Cambridge, MA 0000 00000000000 0000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

AB Science Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore AB Science‘s full profile, request access.

Request full access to PitchBook

AB Science Executive Team (4)

Name Title Board
Seat
Contact
Info
Alain Moussy Co-Founder & Chief Executive Officer
Laurent Guy Chief Financial Officer
Christian Fassotte Global Chief Medical Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »